Sign in

Andi Roy

@roylab-oxford.bsky.social
281 followers 205 following 69 posts

Clinician Scientist and Professor of Paediatric Haematology at University of Oxford. Childhood Leukaemia Research Group, Oxford: Developmental haematopoiesis and leukaemia www.paediatrics.ox.ac.uk/research/p…

PostsRepliesMedia
Andi Roy @roylab-oxford.bsky.social · 06/09/2026
I missed @isehsociety.bsky.social meeting this year. But very proud of these three PhD students representing our lab and presenting their work 👏. #CCAM
021
Andi Roy @roylab-oxford.bsky.social · 30/07/2026
www.nature.com/articles/s41...
nature.com
The effect of cohesin mutations on HLA-class II expression in the myeloid leukemia of Down syndrome - Leukemia
Leukemia - The effect of cohesin mutations on HLA-class II expression in the myeloid leukemia of Down syndrome
000
Andi Roy @roylab-oxford.bsky.social · 23/06/2026
A great time at WIMM Day as always. Great to hear about exciting science. Congratulations to DPhil students from our lab: Alia for presenting her work, and Anna for getting an award for public engagement in research!
010
Andi Roy @roylab-oxford.bsky.social · 05/06/2026
New paper from lab: many congratulations to Rebecca, Alia and Lucy who led this work. And thanks to all collaborators and funders. @paediatrics.ox.ac.uk @imm.ox.ac.uk @oxfordcancer.bsky.social ashpublications.org/blood/articl...
ashpublications.org
The fetal specific gene LIN28B is essential for human fetal B-lymphopoiesis and initiation of KMT2A::AFF1 infant leukemia
Key Points. LIN28B, a fetal specific oncogene, is necessary for fetal B lymphopoiesis and KMT2A::AFF1 initiation of infant B ALLLIN28B stabilizes key fetal
041
Reposted by Andi Roy
MRC Weatherall Institute of Molecular Medicine @imm.ox.ac.uk · 02/06/2026
#ScientistSpotlight 🧪 This week we’re featuring Emily Neil, a Postdoctoral Research Associate at the #MRCWIMM Emily is working on a particularly aggressive and treatment resistant subtype of childhood B cell acute lymphoblastic leukaemia (B ALL), defined by the TCF3::HLF gene fusion.
152
Reposted by Andi Roy
MRC Weatherall Institute of Molecular Medicine @imm.ox.ac.uk · 06/03/2026
This Sunday is #InternationalWomensDay 🧪 Each year we take our Women of WIMM group photo, celebrating women across our entire community, from research and technical teams to professional services. Here is to the women of #MRCWIMM. @rdm.ox.ac.uk @medsci.ox.ac.uk @ox.ac.uk
111
Reposted by Andi Roy
Oxford Cancer @oxfordcancer.bsky.social · 27/02/2026
Oxford's cancer researchers showcased cutting-edge data science and collaboration at @cancerresearchuk.org 's 2026 Data-Driven Cancer Research Conference this week, reinforcing Oxford’s pivotal role in progressing CRUK’s research data strategy. 👏 www.cancer.ox.ac.uk/news/oxford-...
cancer.ox.ac.uk
Oxford Cancer Research Leadership Highlighted at CRUK’s Data-Driven Cancer Research Conference
Oxford University cancer researchers showcased cutting-edge data science and collaboration at Cancer Research UK’s 2026 Data-Driven Cancer Research Conference, reinforcing Oxford’s pivotal role in pro...
031
Andi Roy @roylab-oxford.bsky.social · 27/02/2026
Great 3 days at the @cancerresearchuk.org Data conference in Edinburgh: lots of food for thought. Was good to see #CYP cancer data/AI being discussed.
020
Andi Roy @roylab-oxford.bsky.social · 24/02/2026
Wonderful work @abattacks.bsky.social ! Great to see this out. Many congratulations!
020
Andi Roy @roylab-oxford.bsky.social · 12/02/2026
bloodpodcast.transistor.fm/episodes/147...
bloodpodcast.transistor.fm
Blood Podcast | CAR-iNKT cell immunotherapy and Jagged2/Notch regulation of HSC
In this week's episode, Blood editor Dr. Laurie Sehn interviews authors Drs. Anastasios Karadimitris and Maria Carolina Florian on their papers published in Volume 147 Issue 2 of Blood. Dr. Karadim...
010
Reposted by Andi Roy
Oxford Cancer @oxfordcancer.bsky.social · 12/02/2026
Concluding our interviews for #InternationalDayofWomenAndGirlsInScience2026, hear from DPhil in Cancer Science alumna, Rebecca Ling, now a Clinical Postdoctoral Fellow in @paediatrics.ox.ac.uk ⬇️ @medsci.ox.ac.uk www.cancer.ox.ac.uk/news/interna...
021
Reposted by Andi Roy
MRC Weatherall Institute of Molecular Medicine @imm.ox.ac.uk · 04/02/2026
#WorldCancerDay | When time matters, waiting is not an option. Researchers at #MRCWIMM have developed a readily available immunotherapy approach that showed promise against difficult to treat childhood #leukaemia in early stage #research. 🧪 #ChildhoodCancer #CancerResearch
imm.ox.ac.uk
New ‘off-the-shelf’ immunotherapy shows promise for treating high-risk childhood leukaemia
Scientists at the University of Oxford, together with colleagues at Imperial College London and the University of Glasgow, have developed a new type of immunotherapy that could improve outcomes for in...
195
Reposted by Andi Roy
MRC Weatherall Institute of Molecular Medicine @imm.ox.ac.uk · 04/02/2026
#WorldCancerDay Discovery and early detection matter 🧪 Research at #MRCWIMM shows that platelets carry #DNA, offering new insights into cancer biology and early detection through fundamental science. #CancerResearch #EarlyDetection @bethpsaila.bsky.social @rdm.ox.ac.uk @ox.ac.uk @medsci.ox.ac.uk 🧬
imm.ox.ac.uk
Platelets shown to store DNA in study that could transform cancer screening
Study led by Psaila Group uncovers previously unknown function of platelets as DNA ‘vacuum cleaners’ in the blood, with profound implications for cancer diagnosis and prenatal screening.
082
Andi Roy @roylab-oxford.bsky.social · 30/01/2026
Was wonderful to participate in this symposium. Thanks for the invitation.
030
Andi Roy @roylab-oxford.bsky.social · 28/01/2026
Well done Okan!
020
Reposted by Andi Roy
Oxford Cancer @oxfordcancer.bsky.social · 19/01/2026
Congratulations to the winners of our DPhil in Cancer Science Onco-Innovation Project Sandpit: Michael Bryan, Eva Hanlon, Raul Cioca, Aglaia Skolariki, Nicole Cianci, Roy Rosman Nathanson, Alexandra Petukhova-Greenstein, Anna Prazmo, and Dylan Muldoon! 👏
cancer.ox.ac.uk
Winners of DPhil in Cancer Science Onco-Innovation Project Sandpit Announced
Congratulations to the following DPhil in Cancer Science students — Michael Bryan, Eva Hanlon, Raul Cioca, Aglaia Skolariki, Nicole Cianci, Roy Rosman Nathanson, Alexandra Petukhova-Greenstein, Anna…
031
Reposted by Andi Roy
MRC Weatherall Institute of Molecular Medicine @imm.ox.ac.uk · 16/01/2026
Many congratulations to Lauren Murphy!
022
Andi Roy @roylab-oxford.bsky.social · 12/01/2026
Out in print this week @bloodjournal.bsky.social . Very proud of this collaborative work with Prof Karadimitris @imperialimmuno.bsky.social. Thanks to @cancerresearchuk.org and CwC_UK for funding this work. #InfantALL @paediatrics.ox.ac.uk @imm.ox.ac.uk
084
Andi Roy @roylab-oxford.bsky.social · 05/01/2026
Congratulations Arundhati on passing your DPhil viva with no corrections to your thesis 🎉🍾. So proud of you! Many thanks to examiners Profs Chakraverty and Vormoor. @oxfordcancer.bsky.social @paediatrics.ox.ac.uk @imm.ox.ac.uk
031
Andi Roy @roylab-oxford.bsky.social · 20/12/2025
Merry Christmas and a Happy New Year from our lab! May 2026 bring everything you hope for!
050
Andi Roy @roylab-oxford.bsky.social · 14/11/2025
New lab photo 2025-2026 😊
020
Andi Roy @roylab-oxford.bsky.social · 30/10/2025
Great to see this paper out! Congratulations to first author Alastair Smith and to Tom Milne who led this study. @imm.ox.ac.uk
030
Reposted by Andi Roy
Blood Journals Portfolio @bloodjournals.hematology.org · 27/10/2025
Patient-specific enhancers in genetically uniform leukemias buff.ly/wU28vLW #hemesky
032
Andi Roy @roylab-oxford.bsky.social · 20/10/2025
Happy Diwali from our lab!
030
Andi Roy @roylab-oxford.bsky.social · 17/10/2025
Very proud of Rebecca for getting this CRISCANCER fellowship to continue her clinical academic career! These intermediate fellowships are so valuable for clinician scientists 🎉 @imm.ox.ac.uk @oxfordpaediatrics.bsky.social @oxfordcancer.bsky.social
cancer.ox.ac.uk
Oxford Cancer Announces 2025 CRIS Cancer Clinical Career Fellows
Oxford Cancer, together with the CRIS Cancer Foundation, is delighted to announce the appointment of the 2025 CRIS Cancer Postdoctoral Clinical Fellows: Dr Rebecca Ling and Dr Casmir Turnquist. Both F...
041
Andi Roy @roylab-oxford.bsky.social · 02/10/2025
A news feature from @cancerresearchuk.org about our recent research to close #CCAM.
news.cancerresearchuk.org
Making immunotherapy better for children with acute lymphoblastic leukaemia - Cancer Research UK - Cancer News
iNKT cell therapy could make it possible to stop hard-to-treat forms of leukaemia using donated immune cells.
020
Andi Roy @roylab-oxford.bsky.social · 23/09/2025
Read about our @cclguk.bsky.social @littleprincesses.bsky.social funded research published in @bloodjournals.hematology.org . Well done Joe Cross and Lucy Field. Many thanks to Tom Milne and other collaborators. @oxfordpaediatrics.bsky.social @imm.ox.ac.uk ashpublications.org/bloodadvance...
0144
Andi Roy @roylab-oxford.bsky.social · 22/09/2025
Join me in The Science of Childhood Cancer lecture series hosted by @StJudeResearch this Thursday, September 25 at 12 CT/1pm ET where I will be presenting Developmental origins of infant acute lymphoblastic leukaemia. Register to attend: ow.ly/yzf550T7Iv3
031
Andi Roy @roylab-oxford.bsky.social · 11/09/2025
Had a wonderful time as always at CLRUK annual meeting. It was great fun organising it with Lisa Russell, Karen Keeshan and Bill Grey . Very proud of Lucy Hamer for an excellent talk! #CCAM #bloodcancerawarenessmonth
081
Andi Roy @roylab-oxford.bsky.social · 10/09/2025
Well done to @emilysn1.bsky.social from our group @imm.ox.ac.uk @oxfordpaediatrics.bsky.social for this award from the Kaiya Foundation to study VHR childhood ALL. #CCAM #bloodcancerawareness month. x.com/ttvoxfordshi...
x.com
That's TV Oxfordshire on X: ""Over the next year the plan is to look more specifically at the molecular mechanisms that occur during the initiation of the leukaemia." That's TV spoke to Dr Emily Neil about the grant she has been awarded for her research into leukaemia. https://t.co/MBWB4UAm6K" / X
"Over the next year the plan is to look more specifically at the molecular mechanisms that occur during the initiation of the leukaemia." That's TV spoke to Dr Emily Neil about the grant she has been awarded for her research into leukaemia. https://t.co/MBWB4UAm6K
031
Andi Roy @roylab-oxford.bsky.social · 10/09/2025
See you all in York tomorrow for our annual CLRUK meeting. We have some exciting talks from students and ECRs and a keynote from Prof @adelekfielding.bsky.social
020
Reposted by Andi Roy
Marketa Tomkova @marketatomkova.bsky.social · 05/09/2025
Please share: we’re recruiting a postdoctoral fellow – applications open until September 15! To lead genomics data analysis of an exciting translational project in sAML cancer, supportive environment, and access to unique in-house technologies. my.corehr.com/pls/uoxrecru...
my.corehr.com
Job Details
042
Reposted by Andi Roy
University of Oxford @ox.ac.uk · 04/09/2025
NEW: Scientists at Oxford University, together with colleagues at @imperialcollegeldn.bsky.social and @uofglasgow.bsky.social, have developed a new type of immunotherapy that could improve outcomes for infants and children with high-risk leukaemia. Read more ⬇️
ox.ac.uk
New ‘off-the-shelf’ immunotherapy shows promise for treating
Scientists at the University of Oxford, together with colleagues at Imperial College London and the University of Glasgow, have developed a new type of immunotherapy that could improve outcomes for
0134
Andi Roy @roylab-oxford.bsky.social · 04/09/2025
medicalxpress.com/news/2025-09...
medicalxpress.com
New, 'off-the-shelf' immunotherapy shows promise for treating high-risk childhood leukemia
Scientists at the University of Oxford, together with colleagues at Imperial College London and the University of Glasgow, have developed a new type of immunotherapy that could improve outcomes for in...
070
Andi Roy @roylab-oxford.bsky.social · 03/09/2025
Thanks for highlighting our research!
myscience.org
New ’off-the-shelf’ immunotherapy shows promise for treating high-risk childhood leukaemia
000
Reposted by Andi Roy
MRC Weatherall Institute of Molecular Medicine @imm.ox.ac.uk · 03/09/2025
NEW: Scientists in the @roylab-oxford.bsky.social have co-led the development of a new type of immunotherapy that could improve outcomes for infants and children with high-risk leukaemia 🧪 #ChildhoodCancerAwarenessMonth @oxfordpaediatrics.bsky.social | @medsci.ox.ac.uk Learn more 👇
imm.ox.ac.uk
New ‘off-the-shelf’ immunotherapy shows promise for treating high-risk childhood leukaemia
Scientists at the University of Oxford, together with colleagues at Imperial College London and the University of Glasgow, have developed a new type of immunotherapy that could improve outcomes for in...
083
Andi Roy @roylab-oxford.bsky.social · 02/09/2025
Very grateful for this funding from The Kaiya Foundation to study a rare and aggressive form of childhood ALL. Well done to @emilysn1.bsky.social for this award. #CCAM
030
Reposted by Andi Roy
MRC Weatherall Institute of Molecular Medicine @imm.ox.ac.uk · 01/09/2025
Congratulations to Emily Neil (@emilysn1.bsky.social) & Andi Roy (@roylab-oxford.bsky.social) on receiving one of The Kaiya Foundation's first major research grants. Learn more 👇
041
Andi Roy @roylab-oxford.bsky.social · 25/06/2025
#SAIL Team lunch and meeting in Oxford. An afternoon well spent and some exciting discussions! #infantALL
040
Andi Roy @roylab-oxford.bsky.social · 25/06/2025
WIMM day 2025- talks, posters, discussing science and lab dinner! A good day!
130
Andi Roy @roylab-oxford.bsky.social · 22/06/2025
Dear CLRUK community! The 2025 Annual meeting will be held in York on 11th Sep. We encourage students and postdocs to present their work and ECRs to volunteer as session chairs. Hope to see you all in beautiful York. Register here 👇
forms.office.com
Microsoft Forms
020
Andi Roy @roylab-oxford.bsky.social · 21/06/2025
It’s been a busy time in the lab, with lots of student/postdoc presentations! #ProudPI
120
Reposted by Andi Roy
Andi Roy @roylab-oxford.bsky.social · 21/05/2025
Are you a parent whose child is undergoing/has previously had treatment for cancer? We welcome you to join our infant leukaemia study team (cancer.ox.ac.uk/research/SAIL) to help develop a parent reported outcome questionnaire. Details of how to join/contact us below. Please share.
032
Andi Roy @roylab-oxford.bsky.social · 14/06/2025
Always a pleasure to attend EHA Annual meeting. Well done to WIMM students presenting their work. And a good catch up with all! #EHA2025 @imm.ox.ac.uk
0102
Andi Roy @roylab-oxford.bsky.social · 21/05/2025
Are you a parent whose child is undergoing/has previously had treatment for cancer? We welcome you to join our infant leukaemia study team (cancer.ox.ac.uk/research/SAIL) to help develop a parent reported outcome questionnaire. Details of how to join/contact us below. Please share.
032
Andi Roy @roylab-oxford.bsky.social · 09/05/2025
Well done @ananyam.bsky.social for presenting your research at the @oxfordpaediatrics.bsky.social Student Research Day!
030
Andi Roy @roylab-oxford.bsky.social · 01/05/2025
It was wonderful to have Ana in our lab for a few months. Farewell dinner before her return to Uni of Salamanca
020
Andi Roy @roylab-oxford.bsky.social · 08/03/2025
Happy International Women’s Day to all the great women in science I have been fortunate to know and work with!
nature.com
Behind every great woman in science, there’s another great woman in science
To mark International Women’s Day on 8 March, six award-winning female scientists highlight women who have inspired them by pushing innovative research and creating opportunities for others.
092
Andi Roy @roylab-oxford.bsky.social · 28/02/2025
On rare diseases day, I am really happy to say that our website for the SAIL study is now live. We are collecting clinical and research data and parent reported outcomes for this rare disease in the U.K. Thanks to @cancerresearchuk.org and GOSH Charity for the funding.
cancer.ox.ac.uk
SAIL
Scientific Advances in Infant Acute Lymphoblastic Leukaemia (SAIL) – Establishing an Interactive National Database
032